Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
96.14
-0.08 (-0.08%)
Dec 5, 2025, 4:00 PM EST - Market closed
Merus Market Cap
Merus has a market cap or net worth of $7.29 billion as of December 5, 2025. Its market cap has increased by 140.58% in one year.
Market Cap
7.29B
Enterprise Value
6.49B
1-Year Change
140.58%
Ranking
Category
Stock Price
$96.14
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $7.29B, an increase of 4,999.09%. That is a compound annual growth rate of 50.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 7.30B | 153.49% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |